Last Updated: Sunday, April 20, 2014, 12:27
Ranbaxy Laboratories will cease to exist as a company after completion of the USD 4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets.
Last Updated: Friday, April 18, 2014, 16:59
Cabinet Secretary Ajit Seth has called a meeting of top bureaucrats on Monday to chalk out a strategy to deal with the intellectual property rights (IPR) issues being raised by the US.
Last Updated: Thursday, April 17, 2014, 17:30
GlaxoSmithKline Pharmaceuticals Thursday posted 42.87 percent decline in its net profit at Rs 96.54 crore for the first quarter ended March 31, 2014, as the company continued to be impacted by the revamped price control order.
Last Updated: Wednesday, April 16, 2014, 14:46
The company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone.
Last Updated: Wednesday, April 09, 2014, 22:12
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company Chairman Israel Makov said Wednesday.
Last Updated: Wednesday, April 09, 2014, 18:33
Sun Pharma Wednesday denied insider trading charges against Silverstreet Developers LLP - its wholly owned arm - in the USD 4 billion acquisition deal of Ranbaxy Laboratories.
Last Updated: Wednesday, April 09, 2014, 17:52
Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a USD 3.2 billion takeover of its loss-making rival, sources with direct knowledge of the matter said.
Last Updated: Wednesday, April 09, 2014, 17:38
The scrip ended 6.91 percent up at Rs 627.80 on the BSE. During the day, it surged 8 percent to touch Rs 634.80. Ranbaxy stock rose 4.90 percent to Rs 467.
Last Updated: Wednesday, April 09, 2014, 12:49
On Monday, Bank of America Merrill Lynch also upgraded Sun Pharma to "buy" from "neutral", citing a higher price-to-earnings multiple after Ranbaxy`s acquisition.
Last Updated: Tuesday, April 08, 2014, 12:06
In the biggest deal in two years, Sun Pharmaceutical Industries announced that it will fully acquire rival Ranbaxy Laboratories in an all-stock transaction valued at USD 3.2 billion
Last Updated: Monday, April 07, 2014, 18:54
Sensex Monday closed over 16 points lower with investors turning cautious after the first phase of voting in Lok Sabha elections got under way, amid weakness in global equities.
Last Updated: Monday, April 07, 2014, 09:56
After falling 5.54 percent to Rs 434.05 in intra-day trade on the BSE, shares of Ranbaxy Lab ended 3.12 percent lower at Rs 445.20.
more videos >>